Antitumor therapy based on cellular competition

Human Gene Therapy

Volumn 20, Issue 7, 2009, Pages 728-738

  Martinez Quintanilla, Jordi ^a   Cascallo, Manel ^a   Fillat, Cristina ^b   Alemany, Ramon ^a  

^a CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DIHYDROFOLATE REDUCTASE; GANCICLOVIR; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; METHOTREXATE; RED FLUORESCENT PROTEIN; THYMIDINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BYSTANDER EFFECT; CANCER CELL; CANCER GENE THERAPY; CANCER THERAPY; CELL DEATH; COLON CANCER; CONTROLLED STUDY; FUSION GENE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NEGATIVE SELECTION; NONHUMAN; POSITIVE SELECTION; PROTEIN EXPRESSION; TECHNIQUE; THERAPY EFFECT; TRANSGENE;

ANIMALS; ANTINEOPLASTIC AGENTS; BYSTANDER EFFECT; DRUG RESISTANCE, NEOPLASM; GANCICLOVIR; GREEN FLUORESCENT PROTEINS; HCT116 CELLS; HUMANS; LUMINESCENT PROTEINS; METHOTREXATE; MICE; MICE, INBRED BALB C; NEOPLASMS; TETRAHYDROFOLATE DEHYDROGENASE; THYMIDINE KINASE; TRANSFECTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 68649096534     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2008.144     Document Type: Article

References (31)

1. Banerjee, D., Zhao, S.C., Li, M.X., Schweitzer, B.I., Mineishi, S., and Bertino, J.R. (1994). Gene therapy utilizing drug resistance genes: A review. Stem Cells 12, 378-385.
2. Bertino, J.R., Goker, E., Gorlick, R., Li, W.W., and Banerjee, D. (1996). Resistance mechanisms to methotrexate in tumors. Oncologist 1, 223-226.
3. Bosch, I., and Croop, J. (1996). P-glycoprotein multidrug resistance and cancer. Biochim. Biophys. Acta 1288, F37-F54.
4. Burrows, F.J., Gore, M., Smiley, W.R., Kanemitsu, M.Y., Jolly, D.J., Read, S.B., Nicholas, T., and Kruse, C.A. (2002). Purified herpes simplex virus thymidine kinase retroviral particles. III. Characterization of bystander killing mechanisms in transfected tumor cells. Cancer Gene Ther. 9, 87-95.
5. Campione-Piccardo, J., Rawls, W.E., and Bacchetti, S. (1979). Selective assay for herpes simplex viruses expressing thymidine kinase. J. Virol. 31, 281-287.
6. Carrio, M., Mazo, A., Lopez-Iglesias, C., Estivill, X., and Fillat, C. (2001). Retrovirus-mediated transfer of the herpes simplex virus thymidine kinase and connexin26 genes in pancreatic cells results in variable efficiency on the bystander killing: Implications for gene therapy. Int. J. Cancer 94, 81-88.
7. Cascante, A., Huch, M., Rodriguez, L.G., Gonzalez, J.R., Costantini, L., and Fillat, C. (2005). Tat8-TK/GCV suicide gene therapy induces pancreatic tumor regression in vivo. Hum. Gene Ther. 16, 1377-1388.
8. Culver, K.W., Ram, Z., Wallbridge, S., Ishii, H., Oldfield, E.H., and Blaese, R.M. (1992). In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256, 1550-1552.
9. de Anta, J.M., Mayo, C., Sole, F., Salido, M., Espinet, B., Corzo, C., Petzold, M., Villa, O., Serrano, S., Real, F.X., and Mayol, X. (2006). Methotrexate resistance in vitro is achieved by a dynamic selection process of tumor cell variants emerging during treatment. Int. J. Cancer 119, 1607-1615.
10. Diaz, B., and Moreno, E. (2005). The competitive nature of cells. Exp. Cell Res. 306, 317-322.
11. Dorigo, O., Gil, J.S., Gallaher, S.D., Tan, B.T., Castro, M.G., Lowenstein, P.R., Calos, M.P., and Berk, A.J. (2004). Development of a novel helper-dependent adenovirus-Epstein-Barr virus hybrid system for the stable transformation of mammalian cells. J. Virol. 78, 6556-6566.
12. Ercikan-Abali, E.A., Mineishi, S., Tong, Y., Nakahara, S., Waltham, M.C., Banerjee, D., Chen, W., Sadelain, M., and Bertino, J.R. (1996). Active site-directed double mutants of dihydrofolate reductase. Cancer Res. 56, 4142-4145.
13. Freeman, S.M., Abboud, C.N., Whartenby, K.A., Packman, C.H., Koeplin, D.S., Moolten, F.L., and Abraham, G.N. (1993). The "bystander effect": Tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res. 53, 5274-5283.
14. Hacker, U.T., Wingenfeld, L., Kofler, D.M., Schuhmann, N.K., Lutz, S., Herold, T., King, S.B., Gerner, F.M., Perabo, L., Rabinowitz, J., McCarty, D.M., Samulski, R.J., Hallek, M., and Buning, H. (2005). Adeno-associated virus serotypes 1 to 5 mediated tumor cell directed gene transfer and improvement of transduction efficiency. J. Gene Med. 7, 1429-1438.
15. Immonen, A., Vapalahti, M., Tyynela, K., Hurskainen, H., Sandmair, A., Vanninen, R., Langford, G., Murray, N., and Yla-Herttuala, S. (2004). AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma: A randomised, controlled study. Mol. Ther. 10, 967-972.
16. Jenke, B.H., Fetzer, C.P., Stehle, I.M., Jonsson, F., Fackelmayer, F.O., Conradt, H., Bode, J., and Lipps, H.J. (2002). An episomally replicating vector binds to the nuclear matrix protein SAF-A in vivo. EMBO Rep 3, 349-354.
17. Kreppel, F., and Kochanek, S. (2004). Long-term transgene expression in proliferating cells mediated by episomally maintained high-capacity adenovirus vectors. J. Virol. 78, 9-22.
18. Licht, T., Herrmann, F., Gottesman, M.M., and Pastan, I. (1997). In vivo drug-selectable genes: A new concept in gene therapy. Stem Cells 15, 104-111.
19. Mayer-Kuckuk, P., Banerjee, D., Malhotra, S., Doubrovin, M., Iwamoto, M., Akhurst, T., Balatoni, J., Bornmann, W., Finn, R., Larson, S., Fong, Y., Gelovani Tjuvajev, J., Blasberg, R., and Bertino, J.R. (2002). Cells exposed to antifolates show increased cellular levels of proteins fused to dihydrofolate reductase: A method to modulate gene expression. Proc. Natl. Acad. Sci. U.S.A. 99, 3400-3405.
20. Mayer-Kuckuk, P., Doubrovin, M., Gusani, N.J., Gade, T., Balatoni, J., Akhurst, T., Finn, R., Fong, Y., Koutcher, J.A., Larson, S., Blasberg, R., Tjuvajev, J.G., Bertino, J.R., and Banerjee, D. (2003). Imaging of dihydrofolate reductase fusion gene expression in xenografts of human liver metastases of colorectal cancer in living rats. Eur. J. Nucl. Med. Mol. Imaging 30, 1281-1291.
21. Meisel, R., Bardenheuer, W., Strehblow, C., Sorg, U.R., Elmaagacli, A., Seeber, S., Flasshove, M., and Moritz, T. (2003). Efficient protection from methotrexate toxicity and selection of transduced human hematopoietic cells following gene transfer of dihydrofolate reductase mutants. Exp. Hematol. 31, 1215-1222.
22. Mercola, K.E., Stang, H.D., Browne, J., Salser, W., and Cline, M.J. (1980). Insertion of a new gene of viral origin into bone marrow cells of mice. Science 208, 1033-1035.
23. Mineishi, S., Nakahara, S., Takebe, N., Banerjee, D., Zhao, S.C., and Bertino, J.R. (1997). Co-expression of the herpes simplex virus thymidine kinase gene potentiates methotrexate resistance conferred by transfer of a mutated dihydrofolate reductase gene. Gene Ther. 4, 570-576.
24. Moreno, E., and Basler, K. (2004). dMyc transforms cells into super-competitors. Cell 117, 117-129.
25. Moreno, E., Basler, K., and Morata, G. (2002). Cells compete for decapentaplegic survival factor to prevent apoptosis in Drosophila wing development. Nature 416, 755-759.
26. Nicholas, T.W., Read, S.B., Burrows, F.J., and Kruse, C.A. (2003). Suicide gene therapy with herpes simplex virus thymidine kinase and ganciclovir is enhanced with connexins to improve gap junctions and bystander effects. Histol. Histopathol. 18, 495-507.
27. Rainov, N.G. (2000). A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. Hum. Gene Ther. 11, 2389-2401.
28. Rainov, N.G., and Ren, H. (2003). Clinical trials with retrovirus mediated gene therapy: What have we learned? J. Neurooncol. 65, 227-236.
29. Sauerbrey, A., McPherson, J.P., Zhao, S.C., Banerjee, D., and Bertino, J.R. (1999). Expression of a novel double-mutant dihydrofolate reductase-cytidine deaminase fusion gene confers resistance to both methotrexate and cytosine arabinoside. Hum. Gene Ther. 10, 2495-2504.
30. Unger, M.M., Wahl, J., Ushmorov, A., Buechele, B., Simmet, T., Debatin, K.M., and Beltinger, C. (2007). Enriching suicide gene bearing tumor cells for an increased bystander effect. Cancer Gene Ther. 14, 30-38.
31. Yant, S.R., Ehrhardt, A., Mikkelsen, J.G., Meuse, L., Pham, T., and Kay, M.A. (2002). Transposition from a gutless adenotransposon vector stabilizes transgene expression in vivo. Nat. Biotechnol. 20, 999-1005.